SCHEMBL7258408

SCHEMBL7258408

CCC(CC)c1cccc(C[C@H](N)C(=O)O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 9/20 0.57
NOS3 P29474 3/20 0.57
NOS1 P29475 3/20 0.57
NOS2 P35228 3/20 0.57
PTGS1 P23219 2/20 0.57
ALPI P09923 1/20 0.57
PKM P14618 1/20 0.57
XIAP P98170 1/20 0.57
GRIA2 P42262 1/20 0.55
KDM4E B2RXH2 1/20 0.50
USP2 O75604 1/20 0.50
EGFR P00533 1/20 0.50
LCK P06239 1/20 0.50
FYN P06241 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
ALOX15 P16050 1/20 0.50
HTR2A P28223 1/20 0.50
PTGS2 P35354 1/20 0.50
RECQL P46063 1/20 0.50
HIF1A Q16665 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7257490 0.98 NOS3 (0.56) SLC7A5NOS3NOS1NOS2PTGS1
SCHEMBL22444601 0.84 SLC7A5 (0.61) SLC7A5NOS3NOS1NOS2PTGS1
SCHEMBL16291101 0.84 SLC7A5 (0.61) SLC7A5NOS3NOS1NOS2PTGS1
SCHEMBL6746248 0.83 SLC7A5 (0.59) SLC7A5NOS3NOS1NOS2PTGS1
SCHEMBL22852449 0.82 SLC7A5 (0.54) SLC7A5NOS3NOS1NOS2PTGS1
SCHEMBL18280237 0.82 SLC7A5 (0.57) SLC7A5NOS3NOS1NOS2PTGS1
SCHEMBL5566682 0.82 SLC7A5 (0.57) SLC7A5NOS3NOS1NOS2PTGS1
SCHEMBL16861142 0.82 SLC7A5 (0.57) SLC7A5NOS3NOS1NOS2PTGS1
SCHEMBL2314258 0.82 SLC7A5 (0.77) SLC7A5NOS3NOS1NOS2PTGS1
SCHEMBL15821504 0.81 SLC7A5 (0.66) SLC7A5NOS3NOS1NOS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0728018-B1 New enzymes and prodrugs for ADEPT WELLCOME FOUND (GB) 2003-08-06 EP disclosed
US-6319702-B1 NUCLEOTIDE SEQUENCS CODING AN ENZYMATIC POLYPEPTIDE AND CELL TARGETING COMPOUND; FOR USE IN TREATMENT OF CANCER GLAXO WELLCOME, INC. 2001-11-20 US disclosed
US-6140100-A CONJUGATE POLYPEPTIDE WHICH IS TISSUE PREFERENTIAL; ANTICARCINOGENIC AGENTS GLAXO WELLCOME INC. (US) 2000-10-31 US disclosed
EP-0728018-A1 THERAPY THE WELLCOME FOUNDATION LIMITED (GB) 1996-08-28 EP disclosed
WO-1995013095-A2 THERAPY THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-18 WO disclosed